selected publications
-
Genomic Methods Identify Homologous Recombination Deficiency in Pancreas Adenocarcinoma and Optimize Treatment Selection.
Clinical cancer research : an official journal of the American Association for Cancer Research.
2020
Academic Article
GET IT
Times cited: 138 -
Microsatellite Instability Is Associated With the Presence of Lynch Syndrome Pan-Cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
2018
Academic Article
GET IT
Times cited: 405 -
Prospective Evaluation of Germline Alterations in Patients With Exocrine Pancreatic Neoplasms.
Journal of the National Cancer Institute.
2018
Academic Article
GET IT
Times cited: 180 -
FOLFCIS Treatment and Genomic Correlates of Response in Advanced Anal Squamous Cell Cancer.
Clinical colorectal cancer.
2018
Academic Article
GET IT
Times cited: 22 -
Nanoliposomal irinotecan with fluorouracil for the treatment of advanced pancreatic cancer, a single institution experience.
BMC cancer.
2018
Academic Article
GET IT
Times cited: 72 -
Adoption of Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer.
JAMA oncology.
2018
Academic Article
GET IT
Times cited: 446 -
A First-in-Human Phase 1 Study of LY3023414, an Oral PI3K/mTOR Dual Inhibitor, in Patients with Advanced Cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research.
2018
Academic Article
GET IT
Times cited: 37 -
Incidence, Management, and Implications of Visceral Thrombosis in Pancreatic Ductal Adenocarcinoma.
Clinical colorectal cancer.
2018
Academic Article
GET IT
Times cited: 16 -
Evaluating Mismatch Repair Deficiency in Pancreatic Adenocarcinoma: Challenges and Recommendations.
Clinical cancer research : an official journal of the American Association for Cancer Research.
2018
Academic Article
GET IT
Times cited: 274 -
Clinical Sequencing Defines the Genomic Landscape of Metastatic Colorectal Cancer.
Cancer cell.
2018
Academic Article
GET IT
Times cited: 560 -
First-in-Class ERK1/2 Inhibitor Ulixertinib (BVD-523) in Patients with MAPK Mutant Advanced Solid Tumors: Results of a Phase I Dose-Escalation and Expansion Study.
Cancer discovery.
2017
Academic Article
GET IT
Times cited: 150 -
Clinical and molecular characterization of patients with cancer of unknown primary in the modern era.
Annals of oncology : official journal of the European Society for Medical Oncology.
2017
Academic Article
GET IT
Times cited: 82 -
Erratum: Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients.
2017
GET IT
Times cited: 23 -
Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients.
Nature medicine.
2017
Academic Article
GET IT
Times cited: 2338 -
CAR T-cell therapy for pancreatic cancer.
Journal of surgical oncology.
2017
Information Resource
GET IT
Times cited: 76 -
Clinical and genetic determinants of ovarian metastases from colorectal cancer.
Cancer.
2016
Academic Article
GET IT
Times cited: 51 -
Current management and future directions in metastatic pancreatic adenocarcinoma.
Cancer.
2016
Review
GET IT
Times cited: 21 -
A phase I trial of the Hedgehog inhibitor, sonidegib (LDE225), in combination with etoposide and cisplatin for the initial treatment of extensive stage small cell lung cancer.
Lung cancer (Amsterdam, Netherlands).
2016
Academic Article
GET IT
Times cited: 55 -
Faster FOLFOX: Oxaliplatin Can Be Safely Infused at a Rate of 1 mg/m2/min.
Journal of oncology practice.
2016
Academic Article
GET IT
Times cited: 6 - Genomic Profiling of Cancers of Unknown Primary Site: The Next Steps. JAMA oncology. 2015 Article GET IT
-
Advancing clinical oncology through genome biology and technology.
Genome biology.
2014
Academic Article
GET IT
Times cited: 6 -
Small-cell lung cancers in patients who never smoked cigarettes.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
2014
Academic Article
GET IT
Times cited: 110 -
ALK rearrangements are mutually exclusive with mutations in EGFR or KRAS: an analysis of 1,683 patients with non-small cell lung cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research.
2013
Academic Article
GET IT
Times cited: 531 -
Lungs don't forget: Comparison of the KRAS and EGFR mutation profile and survival of collegiate smokers and never smokers with advanced lung cancers.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
2013
Academic Article
GET IT
Times cited: 26 -
Response to erlotinib in patients with EGFR mutant advanced non-small cell lung cancers with a squamous or squamous-like component.
Molecular cancer therapeutics.
2012
Academic Article
GET IT
Times cited: 44 -
Pemetrexed-based chemotherapy in patients with advanced, ALK-positive non-small cell lung cancer.
Annals of oncology : official journal of the European Society for Medical Oncology.
2012
Academic Article
GET IT
Times cited: 123